Pitfalls of therapies targeting the nitric oxide signaling pathway in heart failure with preserved…
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446151
- Awardee
- Wolters Kluwer Health Inc
- Contracting organization
- University of Virginia
- Contract amount
- Not on record
About this award
The University of Virginia awarded contract A207_PO-0446151 to Wolters Kluwer Health Inc on June 13, 2026. Wolters Kluwer Health Inc serves as the prime contractor under this Virginia-based procurement. The contracting organization, the University of Virginia, represents the procuring entity for this award.
The deliverable under this contract consists of a single line item: a document or resource addressing "Pitfalls of therapies targeting the nitric oxide signaling pathway in heart failure with preserved ejection fraction." The contract specifies delivery to the buyer with a unit of measure designated as "Each" and a unit price of one. While specific contract valuation metrics, including annual value, total contract amount, and cumulative value, are not provided in the available documentation, the contract award was executed in Virginia.
Line items
| Item | Total |
|---|---|
| Pitfalls of therapies targeting the nitric oxide signaling pathway in heart failure with preserved ejection fraction | — |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446151?
Contract A207_PO-0446151 was awarded to Wolters Kluwer Health Inc by University of Virginia on June 13, 2026.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award